At a glance
ClinicalIndex Comparison RecordStandardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Interferon Alfa Sensitivity in HIV/HCV Coinfected Persons Before and After Antiretroviral Therapy
In Brief
A Phase 4 clinical trial evaluating Antiretroviral therapy (ART), raltegravir, and 1 other intervention for HIV Infection and Hepatitis C. Completed, enrolled 20 participants across 1 site.
Detailed Summary
The chief purpose of this research is to evaluate interferon alpha sensitivity and cell type specific levels of interferon receptor and interferon stimulated genes and proteins in HIV/ HCV (hepatitis C virus) coinfected persons before and after administration of HIV medications (antiretroviral therapy).
Study Details
Timeline
Interventions
Peginterferon alfa-2b administered once as part of a pharmacokinetic study before and after anti-HIV medications. Peginterferon is used to produce a measurement but the intervention is the HIV medications which are specified as raltegravir, emtricitabline, and tenofovir disoproxil fumerate.
raltegravir is an HIV medication given 400 mg twice daily by mouth
Emtricitabine and tenofovir disoproxil fumarate are HIV medications, combination pill, once per day by mouth